Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates Company focused on gaining regulatory clarity for late-stage lenabasum program and advancing programs targeting the endocannabinoid system and integrins into the clinicAugmenting the pipeline through...